Neuropathology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.3 | Q3 | 30.0% | 0.538 | Q2 | 63.7% |
| 2024 | 1.2 | Q3 | 31.1% | 0.497 | Q2 | 62.0% |
| 2023 | 1.3 | Q3 | 29.5% | 0.641 | Q2 | 72.9% |
| 2022 | 2.3 | Q3 | 46.8% | 0.666 | Q2 | 75.3% |
| 2021 | 2.1 | Q4 | 35.5% | 0.615 | Q2 | 73.6% |
| 2020 | — | — | 0.701 | Q2 | 76.2% | |
| 2019 | — | — | 0.660 | Q2 | 75.4% | |
| 2018 | — | — | 0.909 | Q1 | 82.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1440-1789
ISSN
0919-6544
region
Western Europe
coverage
1993-2026